ENDRA Life Sciences (NDRA) vs Valion Bio (VBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ENDRA Life Sciences is the larger company by market cap ($9.1 million vs $1.9 million), about 4.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | NDRA | VBIO |
|---|---|---|
| Share price | $6.06 | $2.19 |
| Market cap | $9.09M | $1.94M |
| 1-day change | +0.33% | -7.98% |
| EPS (TTM) | $-6.28 | $-177.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.85 | $78.75 |
| 52-week low | $2.96 | $2.05 |
| Distance from 52-week high | -38.48% | -97.22% |
| Average volume | 36.48K | 1.46M |
| Shares outstanding | 1.50M | 887.59K |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ENDRA Life Sciences is about 4.7 times larger than Valion Bio by market value ($9.09M vs $1.94M).
NDRA vs VBIO FAQ
Which is bigger, ENDRA Life Sciences or Valion Bio?
ENDRA Life Sciences (NDRA) is larger, with a market capitalization of $9.09M compared with $1.94M for Valion Bio (VBIO).
Are ENDRA Life Sciences and Valion Bio in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.